echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > $2.8 billion variety This Anhui pharmaceutical company will take it.

    $2.8 billion variety This Anhui pharmaceutical company will take it.

    • Last Update: 2020-10-17
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Entourtabinofovir tablets contain two active ingredients: entourtabin and fuma acid nofovir difficide, both highly effective antiretroviral drugs.
    entourage nofovir tablets as a single tablet, with simplified treatment, significant efficacy, high patient compliance, low drug resistance and so on, has been included in the national health insurance Class B drugs.
    Truvada, the original manufacturer of Truvada, was first approved by the FDA in August 2004 for the treatment of HIV-1 infection with other antiretroviral drugs, and in 2012 was approved by the FDA for adult-obtained HIV-1 infection due to sexual transmission, the world's first HIV prevention drug.
    2019, Truvada's global sales exceeded $2.8 billion, according to Gilead Financial Results.
    Truvada Global Sales (in millions of U.S. dollars) Source: Minnet Multinational Listed Companies Sales Database The current domestic market Entrutha Binte Nofowe tablet approval enterprises only Gilead and Zhengda Tianqing Pharmaceutical Group, Zhengda Tianqing Pharmaceutical Group in June 2020 won the first imitation of the species;
    Enqutai Bintinofove film pending approval enterprise Source: Minnet one-click search Minet data show that Hesco and Qilu Pharmaceutical's Enqutami Nofowe film listing application in the review, Anhui Baker Bio's Enqutina Bintinofowe film registration status has been changed to "in the approval", if successfully approved will become the second domestic.
    source: MiNet Database, NMPA.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.
    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent Echemi's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.